Suven Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '24
Dec '23
Sep '23
Jun '23
Mar '23
Total Qtr Revenue cr
269.98
234.16
250.90
358.22
380.76
Other Income Qtr Cr17.0514.3419.8410.6711.40
Operating Revenues Qtr252.93219.82231.05347.55369.36

*All values are in Cr.

Operating Expenses Qtr
179.59
154.68
133.09
180.58
200.28
Operating Profit Qtr
73.34
65.14
97.96
166.97
169.08
EBIDT Qtr Cr
90.40
79.49
117.80
177.63
180.48
Depreciation Qtr
17.25
12.75
11.89
12.54
11.96
Net Profit Qtr
53.37
46.75
79.56
120.59
123.97
Basic EPS Qtr
2.10
1.84
3.13
4.74
4.87
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -